RA Guideline Development Partners

The ACR invites letters of interest from those who wish to partner with ACR to develop new clinical practice guidelines for rheumatoid arthritis. The guidelines will cover use of corticosteroids, DMARDs, and biologics, including newer oral agents. Letters of interest must be submitted via e-mail by Monday, July 15.
»Learn More